KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Invested Capital (2016 - 2026)

Chemed filings provide 18 years of Invested Capital readings, the most recent being $848.0 million for Q1 2026.

  • For the quarter ending Q1 2026, Invested Capital fell 28.24% year-over-year to $848.0 million, compared with a TTM value of $848.0 million through Mar 2026, down 28.24%, and an annual FY2025 reading of $979.4 million, down 12.47% over the prior year.
  • Invested Capital hit $848.0 million in Q1 2026 for Chemed, down from $979.4 million in the prior quarter.
  • The five-year high for Invested Capital was $1.2 billion in Q3 2024, with the low at $666.7 million in Q1 2022.
  • Median Invested Capital over the past 5 years was $1.0 billion (2023), compared with a mean of $993.0 million.
  • The sharpest move saw Invested Capital surged 40.31% in 2023, then fell 28.24% in 2026.
  • Year by year, Invested Capital stood at $803.7 million in 2022, then skyrocketed by 37.84% to $1.1 billion in 2023, then rose by 1.0% to $1.1 billion in 2024, then dropped by 12.47% to $979.4 million in 2025, then decreased by 13.42% to $848.0 million in 2026.
  • According to Business Quant data, Invested Capital over the past three periods came in at $848.0 million, $979.4 million, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.